Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.

Cancer treatment and research communications - 1 Jan 2026

Gervaso Lorenzo, Ciardiello Davide, Frassoni Samuele, Bagnardi Vincenzo, Gregato Giuliana, Cella Chiara Alessandra, Benini Lavinia, Tamayo Darina, Spada Francesca, Bertolini Francesco, Fazio Nicola, Zampino Maria Giulia

Abstract excerpt

BACKGROUND: Venous thromboembolism (VTE) is a common complication in cancer patients and negatively affects prognosis. Colorectal cancer (CRC) has the second highest incidence of VTE among the four most common cancers. In locally advanced rectal cancer (LARC), circulating tumor DNA (ctDNA) has emerged as a biomarker of residual disease and tumor burden, but its association with thrombotic risk remains unclear. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Prognosis

Share to Proto-Oncogene Proteins p21(ras)

Share to Rectal Neoplasms

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 42468056
DOI: 10.1016/j.ctarc.2026.101316

Genes

KRAS
BRAF
NRAS
PIK3CA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.PMID 42468056Read ↗

Circulating tumor DNA predicts venous thromboembolism in patients with cancers.Semantic proximity Read ↗

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancerSemantic proximity Read ↗

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.Semantic proximity Read ↗

Genes associated with venous thromboembolism in colorectal cancer patients.Semantic proximity Read ↗

Potential utility of comprehensive genomic profiling to predict venous thromboembolism in patients with solid cancer.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid TumorsSemantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Semantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.